Evaluation of the Extrapulmonary Benefits after Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Pediatric Patients

Authors

Sara Frey PharmD, Lehigh Valley Health NetworkFollow
Shae Duka MPH, Lehigh Valley Health NetworkFollow
Lauren Greenawald DO, Lehigh Valley Health NetworkFollow
Katelin Kimler PharmD, BCPPS, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2022

Comments

Copyright © Lehigh Valley Health Network

Published In/Presented At

Frey, S., Duka, S., Greenawald, L., & Kimler, K. (2022). Evaluation of the extrapulmonary benefits after initiation of Elexacaftor/Tezacaftor/Ivacaftor in pediatric patients. Poster presented at Lehigh Valley Health Network, Allentown, PA.

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Department(s)

Department of Pediatrics, Department of Pharmacy, Department of Pharmacy Faculty, Department of Pharmacy Residents, Fellows and Residents

Document Type

Poster